addiction. Mental and behavioural disorders due to use of other stimulants
Conditions
Interventions
Intervention 1: The intervention group: including 15 people who will first undergo pre-tests and 3 cc of blood sampling, then the members of the experimental group will participate in the lucid dream
Sponsors
The University of Mohaghegh Ardabili
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1- Having a history of using methamphetamine for at least one year (methamphetamine is the main substance used by them) 2- At least two weeks and maximum 6 months have passed since the detoxification period 3- Not taking drugs if they have to take drugs, The type of medicine and dosage should be standardized among patients as much as possible. Having at least 8 years of education
Exclusion criteria
Exclusion criteria: Having psychosis and history of concussions and epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brain derived neurotrophic levels in blood serum. Timepoint: Measurement of serum bdnf level at the beginning of the intervention (before the intervention) and 21 days later. Method of measurement: In order to measure the desired factor using special kits and immunolink enzyme method in the laboratory, serum levels are evaluated to determine the concentration of neurotrophic factor derived from the brain, the serum of each blood sample from Zelbio kit using immunolink enzyme method and based on The instructions of the German manufacturer of the kit will be used. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajjad Basharpoor
Universiry of Mohaghegh Ardabili
Outcome results
None listed